Zyla Life Sciences Gain (Loss) on Derivative Instruments, Net, Pretax
Zyla Life Sciences reported Gain (Loss) on Derivative Instruments, Net, Pretax of $12.29 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-26.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2020-03-26
- Zyla Life Sciences gain (loss) on derivative instruments, net, pretax for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- Zyla Life Sciences gain (loss) on derivative instruments, net, pretax for the quarter ending 2018-09-30 was $3.99M, a 165.73% increase year-over-year.
- Zyla Life Sciences gain (loss) on derivative instruments, net, pretax for the quarter ending 2018-06-30 was $3.18M.
- Zyla Life Sciences gain (loss) on derivative instruments, net, pretax for the quarter ending 2018-03-31 was $5.13M, a 42608.33% increase year-over-year.
- Zyla Life Sciences gain (loss) on derivative instruments, net, pretax for fiscal 2018 was $12.29M, a 382.80% increase from fiscal 2017.
- Zyla Life Sciences gain (loss) on derivative instruments, net, pretax for fiscal 2017 was $2.55M, a 295.34% increase from fiscal 2016.
- Zyla Life Sciences gain (loss) on derivative instruments, net, pretax for fiscal 2016 was $644.00K, a 147.69% increase from fiscal 2015.
- Zyla Life Sciences gain (loss) on derivative instruments, net, pretax for fiscal 2015 was $260.00K.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $3.99M derived: sum of 2 quarters · filed 2020-03-26 | $7.17M derived: sum of 3 quarters · filed 2020-03-26 | $12.29M 10-K · filed 2020-03-26 |
| 2018-09-30 | $3.99M 10-Q · filed 2019-11-14 | $7.17M derived: sum of 2 quarters · filed 2019-11-14 | $12.29M 10-Q · filed 2019-11-14 | $13.32M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $3.18M 10-Q · filed 2018-08-09 | $8.31M 10-Q · filed 2018-08-09 | $9.34M derived: sum of 3 quarters · filed 2019-03-29 | $10.84M derived: sum of 4 quarters · filed 2019-03-29 |
| 2018-03-31 | $5.13M 10-Q · filed 2018-05-10 | $6.16M derived: sum of 2 quarters · filed 2019-03-29 | $7.66M derived: sum of 3 quarters · filed 2019-03-29 | $7.66M derived: sum of 4 quarters · filed 2019-03-29 |
| 2017-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $2.53M derived: sum of 2 quarters · filed 2019-03-29 | $2.53M derived: sum of 3 quarters · filed 2019-03-29 | $2.55M 10-K · filed 2019-03-29 |
| 2017-09-30 | $1.50M 10-Q · filed 2018-11-19 | $1.50M derived: sum of 2 quarters · filed 2018-11-19 | $1.51M 10-Q · filed 2018-11-19 | $1.51M derived: sum of 4 quarters · filed 2018-11-19 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $12.00K 10-Q · filed 2018-08-09 | $14.00K derived: sum of 3 quarters · filed 2018-08-09 | $3.00K derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $12.00K 10-Q · filed 2018-05-10 | $14.00K derived: sum of 2 quarters · filed 2018-05-10 | $3.00K derived: sum of 3 quarters · filed 2018-05-10 | $46.00K derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$9.00K derived: sum of 2 quarters · filed 2018-03-16 | $34.00K derived: sum of 3 quarters · filed 2018-03-16 | $644.00K 10-K · filed 2018-03-16 |
| 2016-09-30 | -$11.00K 10-Q · filed 2017-11-08 | $32.00K derived: sum of 2 quarters · filed 2017-11-08 | $642.00K 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $43.00K 10-Q · filed 2017-08-09 | $653.00K 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | $610.00K 10-Q · filed 2017-05-10 | |||
| 2015-12-31 | $260.00K 10-K · filed 2018-03-16 |